The lawsuit alleges that Eli Lilly, Novo Nordisk and Sanofi, as well as CVS Caremark, Express Scripts and OptumRx, overcharged diabetes patients in the state who require insulin.
The three pharmaceutical companies supply more than 90 percent of the world’s insulin, and the three PBMs “administer pharmacy benefits for roughly 80% of prescription claims managed,” according to a news release from the attorney general’s office.
With the suit, Attorney General Rob Bonta seeks a $2,500 civil penalty from the companies for every violation of the Business and Professions Code outlined in the suit.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.